logo
logo
AI

Discover the World’s Fastest Business Insights

Get real-time alerts on funding rounds, executive hires, acquisitions, and more— plus verified contact details and AI-powered outreach to connect faster.
Sign up now to unlock exclusive data and opportunities.

Myra Vision, A Shifamed Portfolio Company, Closes $17M In Series A Financings

Myra Vision, A Shifamed Portfolio Company, Closes $17M In Series A Financings

06/01/21, 11:22 AM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgcampbell
Money raised
$17 million
Round Type
series a
Myra Vision, a Shifamed portfolio company, announced today the closing of its $17M Series A financings, which will be used to advance product development, scale infrastructure, and expand their team in order to support the development of the first of its kind glaucoma treatment device. The financings were led by The Capital Partnership (TCP), with participation from Cormorant Asset Management and Shifamed angel investors. In conjunction with the financing, the company has changed its name to Myra Vision, Inc. from Myra Medical, Inc.

Company Info

Company
Myra Vision
Location
campbell, kentucky, united states
Additional Info
Myra Vision, a privately held portfolio company of Shifamed LLC, is developing a novel technology that is designed to allow safe outflow control to achieve maximum intraocular pressure (IOP) reduction while also reducing complexity and complication rates. To learn more about Myra Vision, please visit www.myravision.com.
G2 High Performer Badge

Never Miss an Opportunity: Your #1 Sales Intelligence Tool

Get lightning-fast updates on funding rounds, executive hires, contract awards, and more—powered by AI-driven insights to help you connect with the right prospects first.